Literature DB >> 20979996

Polycystic ovary syndrome: an ancient disorder?

Ricardo Azziz1, Daniel A Dumesic, Mark O Goodarzi.   

Abstract

Polycystic ovary syndrome (PCOS) appears to be an ancient disorder, which has persisted in human evolution despite reduced fecundity because of the benefits to affected women such as greater sturdiness and improved energy utilization, a rearing advantage for their children and kin, and a reduction in the risk of perinatal mortality. This raises the possibility that gene variants that are eventually found to be associated with PCOS will be similar across ethnic groups and races.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20979996      PMCID： PMC3164771          DOI： 10.1016/j.fertnstert.2010.09.032

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  31 in total

1.  Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"?

Authors:  J V NEEL
Journal:  Am J Hum Genet       Date:  1962-12       Impact factor: 11.025

2.  An evolutionary approach to explain the high frequency of the polycystic ovary syndrome (PCOS).

Authors:  Sabine Eggers; Dalva Megumi Hashimoto; Sylvia Kirchengast
Journal:  Anthropol Anz       Date:  2007-06

3.  'Diabetes' as described by Byzantine writers from the fourth to the ninth century AD: the Graeco-Roman influence.

Authors:  H Christopoulou-Aletra; N Papavramidou
Journal:  Diabetologia       Date:  2008-05       Impact factor: 10.122

4.  Bone mineral density and body composition in lean women with polycystic ovary syndrome.

Authors:  C Good; M Tulchinsky; D Mauger; L M Demers; R S Legro
Journal:  Fertil Steril       Date:  1999-07       Impact factor: 7.329

5.  Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.

Authors:  Crystal C Douglas; Leigh E Norris; Robert A Oster; Betty E Darnell; Ricardo Azziz; Barbara A Gower
Journal:  Fertil Steril       Date:  2006-06-08       Impact factor: 7.329

6.  Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity.

Authors:  D R Stewart; B A Dombroski; M Urbanek; W Ankener; K G Ewens; J R Wood; R S Legro; J F Strauss; A Dunaif; R S Spielman
Journal:  J Clin Endocrinol Metab       Date:  2006-07-25       Impact factor: 5.958

7.  Family size in women with polycystic ovary syndrome.

Authors:  Marita Pall; Kelley Stephens; Ricardo Azziz
Journal:  Fertil Steril       Date:  2006-05-02       Impact factor: 7.329

8.  Impact of obesity on the risk for polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Eric S Knochenhauer; Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2007-10-09       Impact factor: 5.958

9.  Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization.

Authors:  Shu C Foong; David H Abbott; Michael A Zschunke; Timothy G Lesnick; Jennifer L Phy; Daniel A Dumesic
Journal:  J Clin Endocrinol Metab       Date:  2006-03-21       Impact factor: 5.958

10.  A geographically explicit genetic model of worldwide human-settlement history.

Authors:  Hua Liu; Franck Prugnolle; Andrea Manica; François Balloux
Journal:  Am J Hum Genet       Date:  2006-05-30       Impact factor: 11.025
View more
  39 in total

1.  Genetic variations in SREBP-1 and LXRα are not directly associated to PCOS but contribute to the physiological specifics of the syndrome.

Authors:  Birgit Knebel; Onno E Janssen; Susanne Hahn; Sylvia Jacob; Ulrike Nitzgen; Jutta Haas; Dirk Muller-Wieland; Jorg Kotzka
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

2.  Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity.

Authors:  Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

3.  miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.

Authors:  Jan M McAllister; Angela X Han; Bhavi P Modi; Maria E Teves; Grace R Mavodza; Zachary L Anderson; Tsaiwei Shen; Lane K Christenson; Kellie J Archer; Jerome F Strauss
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

4.  Association between copy-number variation on metabolic phenotypes and HDL-C levels in patients with polycystic ovary syndrome.

Authors:  Birgit Knebel; Stefan Lehr; Onno E Janssen; Susanne Hahn; Sylvia Jacob; Ulrike Nitzgen; Dirk Müller-Wieland; Jorg Kotzka
Journal:  Mol Biol Rep       Date:  2016-11-22       Impact factor: 2.316

5.  Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts.

Authors:  Mark O Goodarzi; Michelle R Jones; Xiaohui Li; Angela K Chua; Obed A Garcia; Yii-Der I Chen; Ronald M Krauss; Jerome I Rotter; Wendy Ankener; Richard S Legro; Ricardo Azziz; Jerome F Strauss; Andrea Dunaif; Margrit Urbanek
Journal:  J Med Genet       Date:  2011-12-17       Impact factor: 6.318

6.  Clustering of PCOS-like traits in naturally hyperandrogenic female rhesus monkeys.

Authors:  D H Abbott; B H Rayome; D A Dumesic; K C Lewis; A K Edwards; K Wallen; M E Wilson; S E Appt; J E Levine
Journal:  Hum Reprod       Date:  2017-04-01       Impact factor: 6.918

Review 7.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

Review 8.  Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?

Authors:  Giovanni Targher; Maurizio Rossini; Amedeo Lonardo
Journal:  Endocrine       Date:  2015-05-30       Impact factor: 3.633

Review 9.  Genetics of the polycystic ovary syndrome.

Authors:  Gülüm Kosova; Margrit Urbanek
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

Review 10.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.